Cheryl Richards added missing citations to bibliography  about 8 years ago

Commit id: 362c6464fe5ff6d0f84bb4b3c49c4eda6a1b2bef

deletions | additions      

       

@misc{vigabatrinPR,  author = {Catalyst {P}harmaceutical {P}artners {I}nc.,}, authors = {Catalyst {{Catalyst  {P}harmaceutical {P}artners {I}nc.,}, {I}nc.,}  # author = {{Catalyst Pharmaceutical Partners, Inc.},}, Inc.},}  # authors = {{Catalyst Pharmaceutical Partners, Inc.},}, Inc.},}},  title = {Catalyst {{Catalyst  {P}harmaceuticals Announces Encouraging Top-Line Results in Proof-of-Concept Trial of Vigabatrin in Patients With Treatment-Refractory {T}ourette's {D}isorder}, {D}isorder}},  year = {2015},  howpublished = {\url{http://ir.catalystpharma.com/releasedetail.cfm?ReleaseID=919254}, archived by WebCite® at http://www.webcitation.org/6hNRye6tt},  url = {http://www.webcitation.org/6hNRye6tt}, 

@article{23876376,  title = {Dopaminergic {{Dopaminergic  activity in {T}ourette syndrome and obsessive-compulsive disorder}, disorder}},  date = {2013 Nov},  source = {Eur Neuropsychopharmacol},  authors = {Denys, D and {de Vries}, F and Cath, D and Figee, M and Vulink, N and Veltman, DJ and {van der Doef}, TF and Boellaard, R and Westenberg, H and {van Balkom}, A and Lammertsma, AA and {van Berckel}, BN}, 

@article{11865128,  title = {Treatment {{Treatment  of {ADHD} in children with tics: a randomized controlled trial}, trial}},  date = {2002 Feb 26},  source = {Neurology},  authors = {{Tourette's Syndrome Study Group},},